NCD Policy Lab

23/12/2025

🎄✨As #2025 draws to a close, the NCD Policy Lab reflects on a year marked by collaboration, evidence generation, and continued engagement to advance access to essential medicines for noncommunicable diseases (NCDs).

Throughout the year, and despite ongoing global challenges, the NCD Policy Lab and its partners strengthened efforts to generate policy-relevant evidence, translate research into actionable outputs, facilitate dialogue between researchers and policymakers, and support collective action to address persistent barriers to access to medicines, diagnostics, and medical devices.
On behalf of all the partners involved in the NCD Policy Lab, warmest wishes are extended to the NCD Policy Lab’s audience & to everyone who has contributed to advancing its mission. The NCD Policy Lab looks forward continuing this important work in the coming year to drive the NCD forward.

🌟 Wishing everyone a joyful holiday season and a New Year filled with inspiration and impact!

Read through for some highlights throughout the year

22/12/2025

Discover highlights from the “New Year’s Table for Type 1 Diabetes” event organized by our partner HPAC, held in Osha on December 14.

During the event, a nutrition expert guided participants through the principles of appropriate nutrition and meal planning for type 1 diabetes, with special attention to the festive season. The practical, hands-on approach helped reinforce key knowledge and build greater confidence in managing diabetes, particularly during the holidays✨

16/12/2025

On 23 September 2025, alongside the UN General Assembly ( ) in New York, the NCD Policy Lab co-organised with NCD Alliance, Access to Medicine Foundation, and Medicines Patent Pool the event “Bridging the Gap: Scaling Innovative Approaches to NCD Medicine Access in LMICs.”
The discussion explored strategies to improve access to treatments for noncommunicable diseases ( ) and mental health conditions in low- and middle-income countries.

By bringing together leaders from global health agencies, pharmaceutical companies, governments, regional health bodies, and civil society, the event highlighted a shared commitment to closing treatment gaps and strengthening country responses to the growing burden of NCDs.

📽️ This recently shared video showcases the main takeaways and promising approaches discussed at the meeting:

This video provides a concise summary of a high-level event held alongside the UN General Assembly, where global leaders voiced strong support for the new Political…

11/12/2025

🔔 Insulin shortages and stockouts are a global problem across geographies and income groups.

In many settings, these disruptions are not occasional but chronic, undermining continuity of care, placing unnecessary pressure on people with diabetes and providers, and widening existing health inequities. Despite being discovered more than a century ago, insulin access remains uneven and, in far too many contexts, uncertain.

"Documenting global Insulin Shortages and Stockouts 2023–2025: Comprehensive overview using various data sources" provides a comprehensive overview of the issue of insulin and , collecting information for the lay press, a review of WHO and government databases as well as questions to the three major insulin manufacturers.

Access to the report here and discover the calls to action proposed👉 https://ncdpolicylab.org/resources/factsheets/documenting-global-insulin-shortages-and-stockouts-2023-2025-comprehensive-overview-using-various-data-sources

11/12/2025

11/12/2025

03/12/2025

Last week, the NCD Policy Lab joined forces with the NCD Alliance to host a focused workshop on advancing access to essential medicines, diagnostics and medical devices ✨

The session brought together voices from World Health Organization (WHO), global access initiatives, organisations and private-sector partners, creating a unique space to align priorities. This workshop was a true success, showcasing the progress and development of solutions first envisioned during last June’s 🚀

A huge thank-you to all participants for their energy, expertise and forward-thinking contributions, which will help shape the next phase of global NCD advocacy.

25/11/2025

Earlier this month, the Lancet Commission on Type 1 Diabetes was featured at , alongside other leading international initiatives working to improve care for people livingwith T1D worldwide 🌍.

International Society for Pediatric and Adolescent Diabetes (ISPAD) once again provided a key platform to highlight new technological advances in management and to address the persistent challenges across diverse settings, including in low- and middle-income countries.

As part of these global efforts, the Lancet T1D Commission is committed to integrating evidence, lived experience, and multidisciplinary perspectives to drive meaningful improvements for people living with type 1 diabetes within the contexts and communities where they live.

In the context of , these global efforts remind us how essential it is to advance equitable, high-quality care for everyone living with T1D 🔵

**
The Lancet Diabetes & Endocrinology Commission on Type 1 Diabetes receives funding from Breakthrough T1D and the World Diabetes Foundation, as well as overall coordination support from the Swiss Development & Cooperation.

24/11/2025

Discover what our partner CRONICAS - Centro de Excelencia en Enfermedades Crónicas in Peru 🇵🇪 contributed for World Diabetes Day.
The team participated in a local health fair, supporting community education on diabetes prevention, healthy eating, and active lifestyles. A meaningful initiative worth highlighting. 🔵

19/11/2025

What drives effective research-policymaker engagement? Why does it matter, on what issues should it focus, with whom should it happen, and when, where and how should researchers meaningfully connect with ?

A new Nature Medicine Perspective by J. Jaime Miranda, David Beran, Rachel Nugent, Francisco Diez-Canseco, Jennifer Sargent, Nyovani Madise, Branwen J. Hennig, Michelle Jimenez, Helena Legido-Quigley, Walter Mendoza, David Peiris, Camila Corvalán and Kent Buse tackles these questions head-on offering tangible recommendations for key stakeholders to help bridge the longstanding gap between and .

These insights resonate strongly with one of the core missions of the NCD Policy Lab: strengthening the science–policy interface and fostering evidence-based policies.

👉 Scroll through the images to see the researcher–policymaker relationship model and the concrete recommendations for each stakeholder.
📄 Read the full paper: https://www.nature.com/articles/s41591-025-04015-9.epdf



CRONICAS - Centro de Excelencia en Enfermedades Crónicas